These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9107450)

  • 1. Can fetal fibronectin testing improve the management of preterm labour?
    Owen P; Scott A
    Clin Exp Obstet Gynecol; 1997; 24(1):19-22. PubMed ID: 9107450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cervical assessment, fetal fibronectin and fetal breathing in the diagnosis of preterm labour.
    Senden IP; Owen P
    Clin Exp Obstet Gynecol; 1996; 23(1):5-9. PubMed ID: 8653936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis.
    Roos C; Vis JY; Scheepers HC; Bloemenkamp KW; Duvekot HJ; van Eyck J; de Groot C; Kok JH; Opmeer BC; Oudijk MA; Papatsonis DN; Porath MM; Sollie K; Spaanderman ME; Lotgering FK; van der Post JA; Mol BW
    J Matern Fetal Neonatal Med; 2016; 29(10):1556-61. PubMed ID: 26103778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
    Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
    Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions.
    Mateus J; Pereira L; Baxter J; Berghella V; Tolosa J
    Am J Perinatol; 2007 Jun; 24(6):381-5. PubMed ID: 17566945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative determination of fetal fibronectin in cervical smears: a new marker for evaluating the risk of premature labor].
    Hampl M; Friese K; Hofmann I; Melchert F
    Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):685-90. PubMed ID: 7851710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population.
    Groom KM; Liu E; Allenby K
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):440-5. PubMed ID: 16953860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks' gestation.
    Parker J; Bell R; Brennecke S
    Aust N Z J Obstet Gynaecol; 1995 Aug; 35(3):257-61. PubMed ID: 8546638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of fetal fibronectin for threatened preterm labour in reducing inappropriate interventions.
    Mahomed K; Anwar S; Geer JE; Ballard E; Okano S
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):523-527. PubMed ID: 30393916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervicovaginal fetal fibronectin testing in threatened preterm labour--translating research findings into clinical practice.
    Chuileannain FN; Bell R; Brennecke S
    Aust N Z J Obstet Gynaecol; 1998 Nov; 38(4):399-402. PubMed ID: 9890218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of cervicovaginal fetal fibronectin status to guide treatment of threatened preterm labour.
    Watson DL; Kim SJ; Humphrey MD
    Aust N Z J Obstet Gynaecol; 1998 May; 38(2):185-7. PubMed ID: 9653857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Presence of fetal fibronectin in cervico-vaginal secretion as predictor of premature labor].
    García Alonso A; Ayala Méndez JA; Izquierdo Puente JC; Jiménez Solís G; Sánchez Martínez M
    Ginecol Obstet Mex; 1999 Jan; 67():23-8. PubMed ID: 10085606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of fetal fibronectin (fFN) expression in cervico-vaginal secretions (CVS)].
    García Alonso LA; Jiménez SG; Ayala Méndez JA; Izquierdo Puente JC; Barahona BE
    Ginecol Obstet Mex; 2002 Aug; 70():379-84. PubMed ID: 12448041
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fetal fibronectin--biomarker for preterm labour].
    Akush Ginekol (Sofiia); 2010; 49(2):39-42. PubMed ID: 20734676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising maternal-fetal outcomes in preterm labour: a decision analysis.
    Macones GA; Bader TJ; Asch DA
    Br J Obstet Gynaecol; 1998 May; 105(5):541-50. PubMed ID: 9637125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Mercer BM; Goldenberg RL; Meis PJ; Moawad AH; Shellhaas C; Das A; Menard MK; Caritis SN; Thurnau GR; Dombrowski MP; Miodovnik M; Roberts JM; McNellis D
    Am J Obstet Gynecol; 2000 Sep; 183(3):738-45. PubMed ID: 10992202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal fibronectin testing for reducing the risk of preterm birth.
    Berghella V; Hayes E; Visintine J; Baxter JK
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD006843. PubMed ID: 18843732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Economical impact of preterm delivery management based on fetal fibronectin results].
    García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
    Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.